TIANDA PHARMA: Xian Yanfang appointed as a member of the Nomination Committee
I'm PortAI, I can summarize articles.
According to the announcement from TIANDA PHARMA, starting from June 27, 2025: Independent non-executive director Zhao Chongkang will no longer serve as a member of the company's nomination committee; independent non-executive director Xian Yanfang has been appointed as a member of the nomination committee; and independent non-executive director Lin Rihui has been appointed as the chief independent non-executive director. The chief independent non-executive director is not an executive position in the company and does not hold any management position in the group
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments